We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Implante bilateral de uma LIO tórica multifocal ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Según presenta un afiche, la implantación bilateral de ...
SALT LAKE CITY, UT--(Marketwired - Jun 14, 2017) - In March 2017, the U.S. Food and Drug Administration approved a new, advanced intraocular lens implant (IOL) called the Acrysof IQ ReSTOR® +2.5 ...
Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...
Alcon Launches AcrySof ReSTOR Apodized Diffractive IOL; Revolutionary Apodized Diffractive Technology Provides Highest Level of Freedom from Glasses American Society of Ophthalmic Administrators (ASOA ...
Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof IQ ReSTOR +2.5 Diopter (D) Intraocular Lens (IOL) ...
GAITHERSBURG, Maryland — The ophthalmic devices advisory committee voted 12-0 that the benefits of the Acrysof IQ ReSTOR intraocular lens made by Alcon (Fort Worth, Texas), outweigh the risks, thus ...
Novartis International AG / Alcon receives US FDA approval for new AcrySof® IQ ReSTOR® +2.5 Multifocal Toric IOL with ACTIVEFOCUS design for uncompromised distance vision and presbyopia correction .